SCHEMBL3128985

SCHEMBL3128985

OCCc1ccc2cnccc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 3/20 0.51
TBXAS1 P24557 1/20 0.44
MELK Q14680 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
ALOX5 P09917 1/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
BACE1 P56817 1/20 0.42
PRMT3 O60678 1/20 0.42
ROCK2 O75116 2/20 0.41
ROCK1 Q13464 1/20 0.41
MYLK4 Q86YV6 1/20 0.41
IMPDH2 P12268 3/20 0.40
HASPIN Q8TF76 1/20 0.40
PDE10A Q9Y233 1/20 0.39
MMP9 P14780 1/20 0.38
RIPK1 Q13546 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29860945 0.85 CYP19A1 (0.54) CYP19A1TBXAS1MELKPRMT3ROCK2
SCHEMBL3144694 0.85 CYP19A1 (0.54) CYP19A1TBXAS1MELKPRMT3ROCK2
SCHEMBL5610449 0.82 KDM4E (0.58) KDM4EALDH1A1ALOX5GAAMAPT
SCHEMBL31349743 0.81 CYP19A1 (0.51) CYP19A1TBXAS1PRMT3IMPDH2PDE10A
SCHEMBL30452839 0.81 CYP19A1 (0.51) CYP19A1TBXAS1MELKKDM4EALDH1A1
SCHEMBL23291124 0.81 CYP19A1 (0.51) CYP19A1TBXAS1MELKKDM4EALDH1A1
SCHEMBL6114451 0.81 CYP19A1 (0.51) CYP19A1TBXAS1PRMT3IMPDH2PDE10A
SCHEMBL3127988 0.81 CYP19A1 (0.51) CYP19A1TBXAS1MELKPRMT3ROCK2
SCHEMBL27503273 0.81 CYP19A1 (0.51) CYP19A1TBXAS1MELKPRMT3ROCK2
SCHEMBL30873955 0.80 CYP1A2 (0.51) CYP19A1TBXAS1PRMT3IMPDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010022055-A2 INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS AMGEN INC. (US) 2010-02-25 WO disclosed
EP-0143333-A1 [Bis(hydroxymethyl)-methyl]-isoquinoline derivatives, process for preparing them and pharmaceutical compositions containing them RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) 1985-06-05 EP disclosed